Price movement over the last 24 hours
ARPA vs Bio Protocol — how do they compare? ARPA trades at Rp160.4 (market cap Rp243,61M, Rp342,26M 24h volume), while Bio Protocol trades at Rp511.08 (market cap Rp1,13T, Rp315,29M 24h volume). The key difference: Bio Protocol is far larger — about 4638.6× ARPA's market cap, and Bio Protocol's supply is capped (2,2B / 3,3B BIO (68%)) while ARPA's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold ARPA for 40 Days and Bio Protocol for 16 Days on average.
| ARPA | BIO | |
|---|---|---|
Market Cap | Rp243,61M | Rp1,13T |
Volume (24h) | Rp342,26M | Rp315,29M |
Circulating Supply | 1,5B ARPA | 2,2B / 3,3B BIO (68%) |
Typical Hold Time | 40 Days | 16 Days |
Signals from Pluang's Aura AI — not financial advice
ARPA is trading at Rp155.55 with a market cap of Rp237.75 million, showing mixed technical signals—bearish moving averages but bullish oscillators. The price hovers near the pivot point of Rp159, with support at Rp148 and resistance at Rp165. No major protocol updates or ecosystem developments were noted recently. Trading volume and network activity remain modest, with a hold time of 40 days indicating moderate investor retention.
Overall outlook is cautious due to conflicting indicators and limited fundamental catalysts. Key opportunities include potential rebounds from support levels, while risks involve low liquidity and bearish trend pressure. Investors should monitor for any ecosystem updates or volume spikes that could shift momentum.
Bio Protocol (BIO) trades at Rp503.72 with a market cap of Rp1.12T, showing a bearish technical outlook as indicated by moving averages. The token's circulating supply is 2.2M out of a max 3.3M, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though specific protocol updates are limited. Key support lies at Rp430, with resistance at Rp522.
Overall outlook is cautious due to bearish signals and neutral oscillators. Opportunities include potential rebounds from oversold RSI levels, but risks involve low liquidity and regulatory uncertainties in the crypto space. Investors should monitor network activity and exchange developments closely.
What Pluang investors did over the last 30 days
ARPA Network (ARPA) is a decentralized secure computation network built to improve the fairness, security, and privacy of blockchains. ARPA threshold BLS signature network serves as the infrastructure of verifiable Random Number Generator (RNG), secure wallet, cross-chain bridge and decentralized custody across multiple blockchains. ARPA was previously known as ARPA Chain, a privacy-preserving Multi-party Computation (MPC) network founded in 2018. ARPA Mainnet has completed over 224,000 computation tasks in the past years.
Read more on ARPA →BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →